Estuary Biotherapeutics launches with $103 million to take gene therapies for kidney disease into the clinic. The financing ...

The clinical-stage biotech has closed an oversubscribed Series D financing round in a bid to meeting its mission to stop ...

Biopharma finance leaders detail how they build and refine gross-to-net models amid shrinking margins across biopharma ...

AstraZeneca pays $40 million upfront to put insitro's AI platform to work on metabolic dysfunction-associated steatohepatitis ...

Zealand Pharma has signed a multi-target collaboration with Generate Biomedicines to design protein therapeutics for obesity ...

Sponsors trialing drugs in the European Union (EU) will be able to continue seeking input from the European Medicines Agency ...

The regulatory professional then does what only they can do; apply scientific and legal judgment, validate the AI's reasoning ...

The collaboration will integrate AI more directly into scientific instrumentation, aiming to close the gap between ...

Study finds Bluesky and X users share clinical trial information differently, which could impact recruitment strategies ...

IgniteData and RealTime eClinical Solutions partner to let RealTime's clinical research sites use IgniteData's Archer ...

Susanne Michel, vice president, head of HTA methods and evidence planning at Clinigen, and Michael Epstein, vice president, ...

Axoltis’ drug, NX210c, failed to meet clinical endpoints in a Phase II trial – but the company says other readouts are ...